After we have established that MYPT1 overexpression can inhibit the metastasis of ccRCC, we examined the expression of major EMT effectors, including E‐cadherin, N‐cadherin and Vimentin. This evidence concerns the gene CDH2 and nonpapillary renal cell carcinoma.